Jump to navigation
The latest clinical and political news for Australian Rheumatologists
Aerobic exercise of any type brings a small benefit.
Weekly dosing needs emphasis.
It may explain why men fare better than women.
They could be having a dual action
Antimalarials rarely tapered down
Methotrexate monotherapy seems to be particularly Australian.
It appears to be better than fish oil supplements.
Response was as quick as a week in some patients.
From leaflets for patients to bone scintigraphy, Aussie rheumatologists had a lot to say.
'Encouraging' results but at higher cost.
A 'clear downward trend' in operations for RA patients.
Anecdotal evidence suggests some health professionals are confused about their use and correct dosage.
They have a very high risk of serious and fatal gastrointestinal bleeds.
They prefer self-manage their symptoms, research shows.
If you can't be there, here are some of the highlights.
The MBS bill more than doubled in two years.
The latest news in rheumatology.
More than 600 delegates converged in Auckland for a smorgasbord of rheumatological delights.
A study shows it relieves pain as much as celecoxib.
From a family friend, to giant cell arteritis
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.